Understanding Lactose Intolerance and Crohn’s Disease

Lactose intolerance and Crohn’s disease both disrupt normal digestion, but they do so in fundamentally different ways. Lactose intolerance is a metabolic issue rooted in enzyme deficiency, while Crohn’s disease is a chronic autoimmune inflammatory condition. Yet a growing body of evidence points to a meaningful overlap between the two, especially regarding how intestinal inflammation can trigger temporary or secondary lactose intolerance. For people living with Crohn’s disease, understanding this connection is key to managing symptoms, avoiding unnecessary dietary restrictions, and maintaining adequate nutrition.

What Is Lactose Intolerance?

Definition and Mechanism

Lactose intolerance occurs when the small intestine does not produce enough lactase, the enzyme responsible for breaking down lactose — the primary sugar in milk and dairy products. Without sufficient lactase, lactose passes undigested into the colon, where gut bacteria ferment it. This fermentation produces gas, fluid, and short-chain fatty acids, leading to symptoms such as bloating, diarrhea, abdominal cramps, and nausea. The severity varies depending on the amount of lactose consumed and the individual’s residual lactase activity.

Types of Lactose Intolerance

  • Primary lactose intolerance — The most common type, caused by a gradual decline in lactase production after weaning, affecting an estimated 65–70% of the global population. It is genetically programmed and varies widely by ethnicity (e.g., low incidence in Northern Europeans, high in East Asians).
  • Secondary lactose intolerance — A temporary condition arising from injury to the small intestinal lining. Conditions such as Crohn’s disease, celiac disease, or acute gastroenteritis can damage the villi, disrupting lactase synthesis. This type is often reversible once the underlying cause is treated.
  • Congenital lactase deficiency — A rare genetic disorder present from birth.
  • Developmental lactose intolerance — Seen in premature infants whose lactase production is not yet mature.

Symptoms and Diagnosis

Symptoms typically appear 30 minutes to two hours after consuming dairy. Common signs include flatulence, diarrhea, cramping, and a sensation of bloating. Diagnosis is often made through a hydrogen breath test, which measures hydrogen levels in the breath after ingesting a lactose solution. An alternative is the lactose tolerance test, which tracks blood glucose changes. Some clinicians also recommend a trial elimination diet followed by challenge.

Prevalence and Demographics

Lactose intolerance is not a disease but a normal biological variation in most of the world’s population. In the United States, about 30–50 million adults are lactose intolerant. The condition is less common in people of Northern European heritage (around 5–15%) and far more prevalent in individuals of African, Asian, Hispanic, and Native American descent (up to 90–100% in some groups). Age also plays a role — lactase production naturally declines with age, so intolerance can develop or worsen in adulthood.

What Is Crohn’s Disease?

Chronic Inflammatory Bowel Disease

Crohn’s disease is one of the two main forms of inflammatory bowel disease (IBD), the other being ulcerative colitis. It is a chronic condition characterized by transmural inflammation — meaning inflammation that can penetrate the full thickness of the bowel wall. It can affect any part of the gastrointestinal tract, from the mouth to the anus, though it most commonly involves the end of the small intestine (ileum) and the beginning of the colon. The inflammation leads to symptoms such as persistent diarrhea, abdominal pain, fatigue, weight loss, and malnutrition. In severe cases, complications like fistulas, abscesses, and bowel obstructions may occur.

Causes and Risk Factors

The exact cause of Crohn’s disease remains unknown, but research points to a complex interaction of genetic susceptibility, environmental triggers, and an inappropriate immune response to gut microbiota. Over 200 gene variants have been associated with IBD, including the NOD2 gene, which plays a role in bacterial recognition. Smoking is a well-established modifiable risk factor that worsens disease activity. Diet and stress may influence symptoms but are not considered direct causes.

Diagnosis and Treatment

Diagnosis typically involves a combination of blood tests (to check for anemia or inflammation markers like C-reactive protein), stool tests (to rule out infection), endoscopy with biopsy, and imaging such as CT or MRI enterography. Treatment aims to reduce inflammation, control symptoms, and prevent relapses. Options include:

  • Aminosalicylates (e.g., mesalamine) — mild to moderate disease
  • Corticosteroids (e.g., prednisone) — short-term acute flares
  • Immunomodulators (e.g., azathioprine, methotrexate) — maintenance therapy
  • Biologics (e.g., anti-TNF agents like infliximab, integrin inhibitors like vedolizumab) — moderate to severe disease
  • Dietary therapy — exclusive enteral nutrition can induce remission in children, and certain elimination diets (e.g., specific carbohydrate diet) are used adjunctively
  • Surgery — resection of damaged bowel segments when medical therapy fails

The Connection Between Lactose Intolerance and Crohn’s Disease

Secondary Lactose Intolerance in Crohn’s Patients

A substantial proportion of people with Crohn’s disease develop secondary lactose intolerance. The inflammation characteristic of Crohn’s, particularly when it occurs in the small intestine, damages the villi — the finger-like projections that produce lactase. This damage reduces lactase activity, making it difficult to digest lactose even if the patient was previously tolerant. Studies report that lactose malabsorption occurs in 12–80% of Crohn’s patients, depending on disease location and activity. The broad range reflects differences in diagnostic methods, patient populations, and disease involvement (ileal vs. colonic).

Dairy as a Symptom Trigger

Even in Crohn’s patients who are not lactose intolerant by strict diagnostic criteria, dairy products may exacerbate symptoms. The reason is twofold: first, the presence of lactose can cause osmotic diarrhea in a gut already struggling with impaired absorption; second, some dairy components (such as casein or whey proteins) may provoke immune or inflammatory responses in susceptible individuals. Additionally, high-fat dairy can slow gastric emptying and contribute to abdominal discomfort. As a result, many Crohn’s patients self-restrict dairy to manage symptoms, often without formal testing.

Research and Epidemiological Data

A 2020 systematic review published in Nutrients found that lactose malabsorption is more prevalent in IBD patients (especially Crohn’s) compared to the general population, and that symptomatic lactose intolerance correlates with disease activity. Another study from the Crohn’s & Colitis Foundation noted that up to 40% of people with Crohn’s disease report dairy as a trigger for gastrointestinal distress, though only a fraction show positive breath tests. This suggests that factors beyond lactase deficiency — such as altered gut motility, increased sensitivity, and changes in the microbiome — contribute to dairy intolerance in Crohn’s.

Differentiating Primary from Secondary

For Crohn’s patients who experience dairy-related symptoms, it is important to determine whether they have primary (genetic) lactose intolerance or secondary (disease-related) intolerance. A hydrogen breath test can help. If the test is negative, symptoms may be due to other components of milk or to the disease itself. If positive, a trial of a low-lactose diet or lactase supplementation may be beneficial. However, because Crohn’s disease is dynamic, a negative test during remission does not rule out future intolerance during flares.

Implications for Diagnosis and Treatment

  • Routine screening — Some gastroenterologists recommend breath testing for lactose intolerance in all newly diagnosed Crohn’s patients, especially those with small bowel involvement or persistent diarrhea.
  • Tailored dietary counseling — A registered dietitian can help patients identify safe sources of dairy (e.g., aged cheeses, lactose-free milk) without sacrificing calcium and vitamin D intake, which is critical for bone health in IBD patients at risk for osteoporosis from steroid use and inflammation.
  • Probiotics and gut healing — Certain probiotic strains (e.g., Lactobacillus, Bifidobacterium) may improve lactose digestion by providing microbial lactase. While more research is needed, probiotics are generally considered safe in IBD and may support overall gut health. Anti-inflammatory therapies that heal the intestinal lining (e.g., biologics, enteral nutrition) can also restore lactase production over time.
  • Lactase enzyme supplements — Over-the-counter lactase tablets or drops can be used when consuming small amounts of lactose, allowing patients to maintain dairy in the diet for nutritional benefits.

Dietary Management: Balancing Symptoms and Nutrition

Low-Lactose vs. Dairy-Free

Not all dairy is high in lactose. Hard cheeses like cheddar, Parmesan, and Swiss contain very little lactose because most of the whey (where lactose resides) is removed during processing. Butter and clarified butter (ghee) are also low in lactose. Yogurt and kefir, especially those containing live active cultures, can be easier to digest because the bacteria produce their own lactase. However, in Crohn’s disease, even low-lactose dairy may be poorly tolerated if the gut is inflamed. A stepwise elimination-reintroduction diet under professional guidance is often the best approach.

Calcium and Vitamin D Alternatives

Avoiding dairy can lead to insufficient calcium and vitamin D intake, which is particularly concerning for Crohn’s patients who already have increased risk for metabolic bone disease. Non-dairy sources of calcium include:

  • Fortified plant milks (almond, soy, oat, rice)
  • Leafy green vegetables (kale, collard greens, broccoli)
  • Calcium-set tofu
  • Canned fish with bones (sardines, salmon)
  • Calcium-fortified orange juice and cereals

Vitamin D can be obtained from sun exposure, fatty fish, egg yolks, and supplements. Since absorption may be compromised in Crohn’s, blood levels should be monitored regularly.

The Role of the Microbiome

The gut microbiome plays a central role in both lactose digestion and inflammation. In secondary lactose intolerance, the microbial community often shifts due to inflammation and antibiotic use. Some research suggests that fecal microbiota transplantation (FMT) may improve lactose digestion in certain populations, though FMT is not yet standard for Crohn’s. More practically, patients may benefit from a diet rich in prebiotic fibers (e.g., oats, bananas, cooked vegetables) that promote beneficial bacteria, provided these are well-tolerated during remission.

Other Trigger Foods

Dairy is not the only dietary concern for Crohn’s patients. Many also find that high-fiber foods, spicy foods, caffeine, alcohol, and high-fat meals worsen symptoms. An anti-inflammatory diet — emphasizing whole foods, omega-3 fatty acids, lean proteins, and easily digestible carbohydrates — can help. The specific carbohydrate diet (SCD) and low-FODMAP diet are often used to identify individual triggers. However, because these diets can be very restrictive, they should only be implemented with expert oversight.

Working with a Healthcare Team

Managing the interplay of lactose intolerance and Crohn’s disease requires collaboration between the patient, gastroenterologist, and registered dietitian. Nutrition support is not one-size-fits-all. Factors such as disease location (ileal vs. colonic), disease activity, medication regimen, and personal history of food intolerances all influence dietary recommendations. The Crohn’s & Colitis Foundation provides evidence-based dietary guidelines, and many academic medical centers offer specialized IBD nutrition clinics.

Treatment Implications and Future Directions

Lactase Testing as a Clinical Tool

Given the high prevalence of secondary lactose intolerance in Crohn’s, a low-cost hydrogen breath test can be a valuable tool in the management plan. A positive result empowers the patient to make informed dietary choices; a negative result can prevent unnecessary elimination of dairy. Some centers are now integrating lactase persistence genotyping (e.g., testing for the LCT gene variant) to distinguish primary from secondary intolerance, though this is not yet routine.

Healing the Gut to Restore Lactase

In cases of secondary intolerance, the most effective long-term strategy is to achieve deep remission of Crohn’s disease so that the intestinal epithelium can heal. Biologic therapies and newer small molecules (e.g., JAK inhibitors) have demonstrated the ability to promote mucosal healing. As the villi regenerate, lactase production may return to baseline. This underscores the importance of treating the underlying disease rather than simply avoiding lactose indefinitely.

Emerging Therapies

Research into lactase-producing probiotics and recombinant lactase enzymes is ongoing. Additionally, studies on the role of dietary short-chain carbohydrates (FODMAPs) in IBD symptoms may provide further insights into why dairy — beyond its lactose content — troubles some Crohn’s patients. The intersection of diet, microbiome, and immune function remains a hot area of investigation, with several clinical trials currently enrolling.

Conclusion

The relationship between lactose intolerance and Crohn’s disease is complex but clinically significant. While the two conditions are not causally linked, Crohn’s-related inflammation frequently impairs lactase production, leading to secondary lactose intolerance. Furthermore, dairy products can exacerbate symptoms in Crohn’s patients through mechanisms that extend beyond lactose malabsorption. For individuals navigating this dual challenge, accurate diagnosis through breath testing, personalized dietary management, and aggressive treatment of the underlying inflammatory disease are the cornerstones of effective care. By addressing both the enzyme deficiency and the inflammatory process, patients can reduce discomfort, improve nutritional status, and achieve a better quality of life.

For more detailed information, readers can consult the Mayo Clinic’s guide to lactose intolerance or the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) page on Crohn’s disease. Always consult a healthcare provider before making significant dietary changes or starting new treatments.